| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.84B | — | +24.2% |
| Cost of Revenue | $203.6M | — | -24.9% |
| R&D Expense | $94.1M | — | -23.4% |
| SG&A Expense | $44.0M | — | -19.2% |
| Operating Income | $1.44B | — | +117.0% |
| Pre-tax Income | $1.43B | — | +131.5% |
| Income Tax | $225.8M | — | +437.9% |
| Net Income | $1.21B | — | +109.2% |
| EPS (Basic) | $3.57 | — | +110.0% |
| EPS (Diluted) | $3.56 | — | +113.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $2.76B | +10.9% | +400.6% |
| Accounts Receivable | $1.96B | +7.6% | +24.1% |
| Current Assets | $4.85B | +9.4% | +104.8% |
| Total Assets | $7.71B | +6.2% | +35.1% |
| Current Liabilities | $1.49B | +12.0% | +6.0% |
| Long-term Debt | $3.51B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $1.29B | — | +55.3% |
| Investing Cash Flow | -$5.2M | — | +76.8% |
| Financing Cash Flow | -$1.01B | — | -1.0% |
| +0.1% |
| Total Liabilities | $5.34B | +4.3% | +4.1% |
| Stockholders' Equity | $2.36B | +10.7% | +310.7% |